Clinical and laboratory features of active pauciarticular JCA (pJCA) patients at the time of the study
| Group A | Group B | |
|---|---|---|
| Patient (n) | 12 | 14 |
| Early onset (n) | 8 | 10 |
| Late onset (n) | 4 | 4 |
| Physician global assessment | 2.9 (0.3) | 2.9 (0.5) |
| Disability index* | 0.6 (0.1) | 0.7 (0.1) |
| CRP (mg/dl) | 2.2 (2.5) | 2.3 (3) |
| ESR (mm/1st h) | 64 (32) | 58.8 (35) |
| Treatment | ||
| NSAID | 3 | 10 |
| No | 9 | 4 |
Group A = < 2 weeks from active arthritis onset; Group B = > 2 weeks from active arthritis onset; * according to the Italian version of the Childhood Health Assessment Questionnaire; CRP = C reactive protein; ESR = erythrocyte sedimentation rate; NSAID = non-steroidal anti-inflammatory drugs. Data shown as number of patients or mean (SD).